Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone

被引:9
作者
Nielsen, D
Eriksen, J
Maare, C
Litman, T
Kjærsgaard, E
Plesner, T
Friche, E
Skovsgaard, T
机构
[1] Univ Copenhagen, Herlev Hosp, Dept Oncol, Copenhagen, Denmark
[2] Univ Copenhagen, Herlev Hosp, Dept Haematol, Copenhagen, Denmark
[3] Univ Copenhagen, Rigshosp, Finsen Ctr, Dept Haematol, DK-2100 Copenhagen, Denmark
关键词
drug resistance; mitoxantrone; multidrug resistance-associated protein; topoisomerase II; tumour cell lines;
D O I
10.1016/S0006-2952(00)00337-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
An Ehrlich ascites tumour cell line (EHR2) was selected in vivo for resistance to mitoxantrone (MITOX). The resistant cell line (EHR2/MITOX) was 6123-, 33-, and 30-fold-resistant to mitoxantrone, daunorubicin, and etoposide, respectively, but retained sensitivity to vincristine. The resistant cells showed moderate sensitisation to mitoxantrone on treatment with verapamil or cyclosporin A. Compared with EHR2, the multidrug resistance-associated protein mRNA was increased 13-fold in EHR2/MITOX. Western blot analysis showed an unchanged, weak expression of P-glycoprotein. Topoisomerase II alpha was reduced to one-third in EHR2/MITOX relative to EHR2 cells, whereas topoisomerase II beta was present in EHR2 but could not be detected in EHR2/MITOX. In the resistant subline, net accumulation of MITOX (120 min) and daunorubicin (60 min) was reduced by 43% and 27%, respectively, as compared with EHR2. The efflux of daunorubicin from preloaded EHR2/MITOX cells was significantly increased. EHR2/MITOX microsomes had a significant basal unstimulated ATPase activity. The apparent K-i value for vanadate inhibition of the ATPase activity in EHR2/MITOX microsomes was not significantly different from the K-i value for P-glycoprotein-positive cells. However, whereas verapamil (50 mu M) inhibited the ATPase activity of EHR2/MITOX microsomes, it stimulated the ATPase activity of microsomes derived from P-glycoprotein-positive cells. In conclusion, the resistance in EHR2/MITOX was multifactorial and appeared to be associated with: 1) a quantitative reduction in topoisomerase II alpha and beta protein; 2) reduced drug accumulation, probably as a result of increased expression of a novel transport protein with ATPase activity; and 3) increased expression of MRP mRNA. BIOCHEM PHARMACOL 60;3:363-370, 2000. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:363 / 370
页数:8
相关论文
共 41 条
  • [1] Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity
    Borgnia, MJ
    Eytan, GD
    Assaraf, YG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) : 3163 - 3171
  • [2] ATPase activity of purified multidrug resistance-associated protein
    Chang, XB
    Hou, YX
    Riordan, JR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) : 30962 - 30968
  • [3] A METHOD FOR THE DETERMINATION OF INORGANIC-PHOSPHATE IN THE PRESENCE OF LABILE ORGANIC PHOSPHATE AND HIGH-CONCENTRATIONS OF PROTEIN - APPLICATION TO LENS ATPASES
    CHIFFLET, S
    TORRIGLIA, A
    CHIESA, R
    TOLOSA, S
    [J]. ANALYTICAL BIOCHEMISTRY, 1988, 168 (01) : 1 - 4
  • [4] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [5] COLE SPC, 1994, CANCER RES, V54, P5902
  • [6] OVEREXPRESSION OF A TRANSPORTER GENE IN A MULTIDRUG-RESISTANT HUMAN LUNG-CANCER CELL-LINE
    COLE, SPC
    BHARDWAJ, G
    GERLACH, JH
    MACKIE, JE
    GRANT, CE
    ALMQUIST, KC
    STEWART, AJ
    KURZ, EU
    DUNCAN, AMV
    DEELEY, RG
    [J]. SCIENCE, 1992, 258 (5088) : 1650 - 1654
  • [7] IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES)
    CORDELL, JL
    FALINI, B
    ERBER, WN
    GHOSH, AK
    ABDULAZIZ, Z
    MACDONALD, S
    PULFORD, KAF
    STEIN, H
    MASON, DY
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) : 219 - 229
  • [8] DALTON WS, 1988, CANCER RES, V48, P1882
  • [9] ALTERED CATALYTIC ACTIVITY OF AND DNA CLEAVAGE BY DNA TOPOISOMERASE II FROM HUMAN-LEUKEMIC CELLS SELECTED FOR RESISTANCE TO VM-26
    DANKS, MK
    SCHMIDT, CA
    CIRTAIN, MC
    SUTTLE, DP
    BECK, WT
    [J]. BIOCHEMISTRY, 1988, 27 (24) : 8861 - 8869
  • [10] MORPHOLOGICAL ALTERATIONS IN DRUG SENSITIVE VS DRUG-RESISTANT CELLS DUE TO CYSTOSTATIC APPLICATION
    DIETEL, M
    SEIDEL, A
    [J]. CANCER TREATMENT REVIEWS, 1990, 17 : 3 - 10